Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
BIOLOGICAL SCIENCES / CELL BIOLOGY / MEDICAL SCIENCES
Bcl10 and Malt1 control lysophosphatidic acid-induced NF-B activation and cytokine production
Stefanie Klemm*,
Stephanie Zimmermann*,
Christian Peschel*,
Tak W. Mak,, and
Jürgen Ruland*,
*Third Medical Department, Technical University of Munich, Klinikum Rechts der Isar, Ismaninger Strasse 22, 81675 Munich, Germany; and The Campbell Family Institute for Breast Cancer Research and Ontario Cancer Institute, University Health Network, University of Toronto, Toronto, ON, Canada M5G 2C1
Contributed by Tak W. Mak, September 25, 2006
Abstract:
Lysophosphatidic acid (LPA) is a potent bioactive phospholipidthat stimulates a variety of cellular responses by acting oncognate G protein-coupled receptors (GPCRs). There is increasingevidence that LPA signaling reprograms gene expression, butthe GPCR-induced pathways connecting LPA receptor stimulationto downstream transcription factors are not well characterized.Here, we identify the adapter proteins Bcl10 and Malt1 as essentialmediators of LPA-induced NF-B activation. Both proteins werepreviously known to activate NF-B in response to antigen receptorligation on lymphocytes, but their functions in nonimmune cellsare still largely undefined. By using murine embryonic fibroblastsfrom Bcl10- or Malt1-deficient mice as a genetic model, we reportthat Bcl10 and Malt1 are critically required for the degradationof IB- and the subsequent NF-B induction in response to LPAstimulation. Bcl10 and Malt1 cooperate with PKCs selectivelyfor LPA-induced NF-B activation but are dispensable for theactivation of the Jnk, p38, Erk MAP kinase, and Akt signalingpathways. In a biological readout, we demonstrate that LPA-inducedIL-6 production is abolished in the absence of Bcl10. Thus,our results identify a NF-B-inducing signaling pathway downstreamof GPCRs and reveal previously unrecognized functions for Bcl10/Malt1signaling in nonimmune cells.
Key Words: G protein-coupled receptor signal transduction
Author contributions: J.R. and T.W.M. designed research; S.K.and S.Z. performed research; S.K., S.Z., C.P., T.W.M., and J.R.analyzed data; and S.K., T.W.M., and J.R. wrote the paper.
The authors declare no conflict of interest.
To whom correspondence may be addressed. E-mail: tmak{at}uhnres.utoronto.ca or jruland{at}lrz.tum.de
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Nancy R. Gough (9 January 2007) Sci. STKE2007 (368), tw12.
[DOI: 10.1126/stke.3682007tw12] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
MALT1 Protease: A New Therapeutic Target in B Lymphoma and Beyond?.
L. M. McAllister-Lucas, M. Baens, and P. C. Lucas (2011)
Clin. Cancer Res.
17, 6623-6631
|Abstract »|Full Text »|PDF »
The E3 Ubiquitin Ligase Mind Bomb-2 (MIB2) Protein Controls B-cell CLL/Lymphoma 10 (BCL10)-dependent NF-{kappa}B Activation.
C. C. Stempin, L. Chi, J. P. Giraldo-Vela, A. A. High, H. Hacker, and V. Redecke (2011)
J. Biol. Chem.
286, 37147-37157
|Abstract »|Full Text »|PDF »
Specific effects of BCL10 Serine mutations on phosphorylations in canonical and noncanonical pathways of NF-{kappa}B activation following carrageenan.
S. Bhattacharyya, A. Borthakur, A. N. Anbazhagan, S. Katyal, P. K. Dudeja, and J. K. Tobacman (2011)
Am J Physiol Gastrointest Liver Physiol
301, G475-G486
|Abstract »|Full Text »|PDF »
CARMA3 is Crucial for EGFR-Induced Activation of NF-{kappa}B and Tumor Progression.
T. Jiang, B. Grabiner, Y. Zhu, C. Jiang, H. Li, Y. You, J. Lang, M.-C. Hung, and X. Lin (2011)
Cancer Res.
71, 2183-2192
|Abstract »|Full Text »|PDF »
Thrombin-dependent NF-{kappa}B Activation and Monocyte/Endothelial Adhesion Are Mediated by the CARMA3{middle dot}Bcl10{middle dot}MALT1 Signalosome.
P. C. Delekta, I. J. Apel, S. Gu, K. Siu, Y. Hattori, L. M. McAllister-Lucas, and P. C. Lucas (2010)
J. Biol. Chem.
285, 41432-41442
|Abstract »|Full Text »|PDF »
Tumor Necrosis Factor Receptor-associated Factor-6 and Ribosomal S6 Kinase Intracellular Pathways Link the Angiotensin II AT1 Receptor to the Phosphorylation and Activation of the I{kappa}B Kinase Complex in Vascular Smooth Muscle Cells.
Protein Phosphatase 2A Acts as a Mitogen-activated Protein Kinase Kinase Kinase 3 (MEKK3) Phosphatase to Inhibit Lysophosphatidic Acid-induced I{kappa}B Kinase {beta}/Nuclear Factor-{kappa}B Activation.
W. Sun, H. Wang, X. Zhao, Y. Yu, Y. Fan, H. Wang, X. Wang, X. Lu, G. Zhang, S. Fu, et al. (2010)
J. Biol. Chem.
285, 21341-21348
|Abstract »|Full Text »|PDF »
Phosphorylation of Thr-516 and Ser-520 in the Kinase Activation Loop of MEKK3 Is Required for Lysophosphatidic Acid-mediated Optimal I{kappa}B Kinase {beta} (IKK{beta})/Nuclear Factor-{kappa}B (NF-{kappa}B) Activation.
W. Sun, N. Ge, Y. Yu, S. Burlingame, X. Li, M. Zhang, S. Ye, S. Fu, and J. Yang (2010)
J. Biol. Chem.
285, 7911-7918
|Abstract »|Full Text »|PDF »
B-cell CLL/Lymphoma 10 (BCL10) Is Required for NF-{kappa}B Production by Both Canonical and Noncanonical Pathways and for NF-{kappa}B-inducing Kinase (NIK) Phosphorylation.
S. Bhattacharyya, A. Borthakur, S. Tyagi, R. Gill, M. L. Chen, P. K. Dudeja, and J. K. Tobacman (2010)
J. Biol. Chem.
285, 522-530
|Abstract »|Full Text »|PDF »
Epigenetic Loss of Mucosa-Associated Lymphoid Tissue 1 Expression in Patients with Oral Carcinomas.
T. Chiba, G. Maeda, S. Kawashiri, K. Kato, and K. Imai (2009)
Cancer Res.
69, 7216-7223
|Abstract »|Full Text »|PDF »
CXCL8/IL8 Stimulates Vascular Endothelial Growth Factor (VEGF) Expression and the Autocrine Activation of VEGFR2 in Endothelial Cells by Activating NF{kappa}B through the CBM (Carma3/Bcl10/Malt1) Complex.
D. Martin, R. Galisteo, and J. S. Gutkind (2009)
J. Biol. Chem.
284, 6038-6042
|Abstract »|Full Text »|PDF »
CARMA3 Mediates Lysophosphatidic Acid-Stimulated Cytokine Secretion by Bronchial Epithelial Cells.
B. D. Medoff, A. L. Landry, K. A. Wittbold, B. P. Sandall, M. C. Derby, Z. Cao, J. C. Adams, and R. J. Xavier (2009) 40, 286-294
|Abstract »|Full Text »|PDF »
Multiple Protein Domains Mediate Interaction between Bcl10 and MALT1.
F. D. Langel, N. A. Jain, J. S. Rossman, L. M. Kingeter, A. K. Kashyap, and B. C. Schaefer (2008)
J. Biol. Chem.
283, 32419-32431
|Abstract »|Full Text »|PDF »
{beta}-Arrestin 2 is required for lysophosphatidic acid-induced NF-{kappa}B activation.
Toll-like Receptor 4 Mediates Induction of the Bcl10-NF{kappa}B-Interleukin-8 Inflammatory Pathway by Carrageenan in Human Intestinal Epithelial Cells.
S. Bhattacharyya, R. Gill, M. L. Chen, F. Zhang, R. J. Linhardt, P. K. Dudeja, and J. K. Tobacman (2008)
J. Biol. Chem.
283, 10550-10558
|Abstract »|Full Text »|PDF »
Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti.
H. Sebban-Benin, A. Pescatore, F. Fusco, V. Pascuale, J. Gautheron, S. Yamaoka, A. Moncla, M. V. Ursini, and G. Courtois (2007)
Hum. Mol. Genet.
16, 2805-2815
|Abstract »|Full Text »|PDF »
Bcl10 mediates LPS-induced activation of NF-{kappa}B and IL-8 in human intestinal epithelial cells.
S. Bhattacharyya, A. Borthakur, N. Pant, P. K. Dudeja, and J. K. Tobacman (2007)
Am J Physiol Gastrointest Liver Physiol
293, G429-G437
|Abstract »|Full Text »|PDF »
CARD-Bcl10-Malt1 Signalosomes: Missing Link to NF-{kappa}B.
CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation.
B. C. Grabiner, M. Blonska, P.-C. Lin, Y. You, D. Wang, J. Sun, B. G. Darnay, C. Dong, and X. Lin (2007)
Genes & Dev.
21, 984-996
|Abstract »|Full Text »|PDF »